1. Heidelbaugh J, Hungin P, Guest Eds, editors. Drossman DA,
Chang L, Kellow J, Chey WD, Tack J, Whitehead WE, editors.
The Rome IV Primary Care Committee. Rome IV functional
gastrointestinal disorders for primary care and non-GI
clinicians. 1st ed. Raleigh, NC: The Rome Foundation, 2016.
2. Lovell RM, Ford AC. Global prevalence of and risk factors for
irritable bowel syndrome: a meta-analysis. Clin Gastroenterol
Hepatol 2012 ;10:712-1. doi:10.1016/j.cgh.2012.02.029
3. Celebi S, Acik Y, Deveci SE, et al.Epidemiological features
of irritable bowel syndrome in a Turkish urban society. J
Gastroenterol Hepatol 2004;19:738-43. doi: 10.1111/j.1400-
1746.2004.03367.x
4. Özden A, Köksal ŞA, Oğuz D, et al. Türkiye’de birinci basamak
sağlık kurumlarında irritabl barsak sendromu görülme sıklığı.
Akademik Gastroenteroloji Dergisi 2006; 5: 4-15.
5. Lee OY, Mayer EA, Schmulson M, Chang L, Naliboff B. Genderrelated
differences in IBS symptoms. Am J Gastroenterol
2001;96:2184-93. doi:10.1016/S0002-9270(01)02524-2